Erythromycin A enol ether

CAS No. 33396-29-1

Erythromycin A enol ether ( —— )

Catalog No. M27430 CAS No. 33396-29-1

Erythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 246 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
500MG 2313 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Erythromycin A enol ether
  • Note
    Research use only, not for human use.
  • Brief Description
    Erythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.
  • Description
    Erythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    33396-29-1
  • Formula Weight
    715.9
  • Molecular Formula
    C37H65NO12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O([C@H]1[C@]2(C)OC(=C(C)C2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@@H]1C)[C@H]4[C@H](O)[C@@H](N(C)C)C[C@@H](C)O4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chen X, et al. Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells. J Ophthalmol. 2018;2018:6128470.
molnova catalog
related products
  • DL-α-Hydroxyglutaric...

    DL-α-Hydroxyglutaric acid disodium salt is an α -hydroxyacid formed from the hydrolysis of (R) -5-oxy-2-tetrahydrofuran carboxylic acid, which is overproduced in human neurometabolic disease D-α -hydroxyglutaric uria. ?

  • Morusin

    Morusin possesses antitumor effects of cell lines including HT-29, A549, MCF-7 and MDA-MB-231, through suppressing STAT3 and NFκB attenuation mediated apoptosis induction.

  • FFAGLDD

    FFAGLDD is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release.